Domestic new drug No. 1, Sunpla inj. approved

Published: 1999-07-19 10:29:00

Updated: 1999-07-19 10:29:00

The KFDA approved Sunpla inj., a platinum chelate complex anticancer drug, as the first new drug originated from Korea on July 13, which was developed by SK Pharmaceutical (President: Cho Min-ho) at 8.1 billion won of its R&D investment during the past 9 years. Its generic name is Heptaplatin.
A clinical study showed its excellent therapeutic effect in combination with 5-Fluorouracil for the ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.